Hong Kong stocks in innovative pharmaceutical concept stocks continue to strengthen, Lepu Medical-B rises more than 17%

On April 1st, the price of Luoping Biological-B stock fluctuated upward, rising more than 17% at one point. As of 13:29, the stock had risen by 14.98%, reaching 6.14 Hong Kong dollars per share. Other Hong Kong-listed innovative pharmaceutical stocks also showed strong performance, with Biostime Pharmaceutical-B and Sino Pharmaceutical Group both rising by more than 5%, Sanofi Pharmaceutical rising by more than 11%, and Sundy Land and Zhaoyan Pharmaceuticals rising by more than 8%.